C16-Ceramide Analog Combined with Pc 4 Photodynamic Therapy Evokes Enhanced Total Ceramide Accumulation, Promotion of DEVDase Activation in the Absence of Apoptosis, and Augmented Overall Cell Killing
about
A review of ceramide analogs as potential anticancer agentsCeramide synthase inhibitor fumonisin B1 inhibits apoptotic cell death in SCC17B human head and neck squamous carcinoma cells after Pc4 photosensitization.Combining anticancer agents photodynamic therapy and LCL85 leads to distinct changes in the sphingolipid profile, autophagy, caspase-3 activation in the absence of cell death, and long-term sensitizationEnhanced killing of SCC17B human head and neck squamous cell carcinoma cells after photodynamic therapy plus fenretinide via the de novo sphingolipid biosynthesis pathway and apoptosisC6 pyridinium ceramide influences alternative pre-mRNA splicing by inhibiting protein phosphatase-1.C6-pyridinium ceramide sensitizes SCC17B human head and neck squamous cell carcinoma cells to photodynamic therapyCationic ceramides and analogues, LCL30 and LCL85, as adjuvants to photodynamic therapy of tumors.Increased killing of SCCVII squamous cell carcinoma cells after the combination of Pc 4 photodynamic therapy and dasatinib is associated with enhanced caspase-3 activity and ceramide synthase 1 upregulation.Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cellssiRNA-mediated down-regulation of ceramide synthase 1 leads to apoptotic resistance in human head and neck squamous carcinoma cells after photodynamic therapy.Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents.
P2860
Q27009351-C8D761D3-150B-4580-9881-FB3C682D60D3Q34770575-6FB449D8-E89F-4135-A2C2-BAFDAACBBAABQ35069168-2D16B5D5-6B6B-45D7-A58B-959F6817A816Q35247192-A324AB2F-B5C2-450B-B8BE-27FB5C114D77Q35955993-D3650845-D6F1-4864-9D24-52A175F9CA0FQ36326049-8AF4243B-130D-40D9-BBB2-AA21AD56092DQ37163553-C2325382-34FF-4A28-B7F1-75F64FB6C818Q37326151-15F34DEB-593B-4D62-8924-0E3224417664Q37527263-2493B10D-16B6-468F-96F7-186AF89ABDC1Q37603503-0C2992CE-40C3-42E5-AA8B-586EFB05FE08Q38831997-8C27AA8B-8C11-4945-B2C2-6F9DD924362B
P2860
C16-Ceramide Analog Combined with Pc 4 Photodynamic Therapy Evokes Enhanced Total Ceramide Accumulation, Promotion of DEVDase Activation in the Absence of Apoptosis, and Augmented Overall Cell Killing
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
C16-Ceramide Analog Combined w ...... Augmented Overall Cell Killing
@ast
C16-Ceramide Analog Combined w ...... Augmented Overall Cell Killing
@en
C16-Ceramide Analog Combined w ...... Augmented Overall Cell Killing
@nl
type
label
C16-Ceramide Analog Combined w ...... Augmented Overall Cell Killing
@ast
C16-Ceramide Analog Combined w ...... Augmented Overall Cell Killing
@en
C16-Ceramide Analog Combined w ...... Augmented Overall Cell Killing
@nl
prefLabel
C16-Ceramide Analog Combined w ...... Augmented Overall Cell Killing
@ast
C16-Ceramide Analog Combined w ...... Augmented Overall Cell Killing
@en
C16-Ceramide Analog Combined w ...... Augmented Overall Cell Killing
@nl
P2093
P2860
P356
P1433
P1476
C16-Ceramide Analog Combined w ...... Augmented Overall Cell Killing
@en
P2093
Alicja Bielawska
Duska Separovic
Eric Van Buren
Ethan A Edwin
Jacek Bielawski
Jason S Pierce
Ziad H Saad
P2860
P304
P356
10.1155/2011/713867
P577
2010-12-14T00:00:00Z